Citations

Showing 10 of 108094 citations.

Elevated plasma homocysteine level is associated with poor ST-segment resolution in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention at high altitude
Liu, Bei , Yang, Lixia , Guo, Ruiwei , Yang, Shujuan , Zhang, Bin , Guo, Ruiwei

Mayo Clinic

Cardiology Plus | July 27, 2022 | Volume: 7 | Issue: 2 | Pages: 92-96

10.1097/cp9.0000000000000016 Get It

Abstract Background and purpose: Poor ST-segment resolution (STR) is strongly associated with poor prognosis in patients with ST segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). previous studies suggested higher HCY level in the people who live in high altitudes, so a retrospective analysis is conducted to examine the potential relationship between elevated serum HCY and poor STR after PPCI at high altitudes. Methods: This retrospective analysis included 308 high-altitude dwelling patients (1800-2200 meters elevation from the sea level) undergoing PPCI for STEMI during a period from September 2021 to March 2022. Clinical data were collected and statistically analyzed. Results: In comparison to the patients with normal plasma homocysteine (≤15 mmol/L; n = 155), patients with elevated homocysteine (>15 mmol/L) had higher percentage of men (92.81% vs. 80.00%; p = 0.001) and smoker (79.08% vs. 63.87%; p = 0.003), but no difference in other key baseline characteristics. The rate of complete ST-segment resolution after PPCI (≥ 70%) was 83.23% in the control group and 49.67% in the elevated HCY group (p ≤ 0.001). In multivariable regression analysis, poor ST-segment resolution (<70%) was independently associated with longer pain-to-balloon time (OR 0.832; 95%CI: 0.775–0.894), lower uric acid (OR 1.003; 95%CI: 1.000-1.005), and elevated HCY (OR 0.957 vs. normal HCY; 95%CI: 0.937–0.977). Conclusion: Elevated plasma HCY level was associated with poor ST segment resolution in patients undergoing PPCI STEMI at high altitude.
Endometriosis biomarkers of the disease: an update
Soto, Diana Encalada , Rassier, Sarah, Green, Isabel C. , Khan, Zaraq , Rassier, Sarah L. Cohen , Burnett, Tatnai L. , Cope, Adela G.

Mayo Clinic

Current Opinion in Obstetrics & Gynecology | July 27, 2022 | Volume: 34 | Issue: 4 | Pages: 210-219

10.1097/gco.0000000000000798 | PMID 35895963 Get It

Purpose of review Endometriosis is a complex benign gynaecologic condition with heterogenous presentations and a large impact on the global healthcare system and on the quality of life for millions of women. Currently, the gold standard for diagnosis involves direct visualization of lesions during surgery confirmed by histopathological diagnosis, resulting in an average delay in its initial diagnosis of 8–10 years. Therefore, the search for noninvasive diagnostic testing options has been subject to a large body of research. Recent findings Multiple potential biomarkers have been explored for noninvasive testing for endometriosis, including glycoproteins, inflammatory cytokines, immunological molecules, angiogenesis markers, hormones, micro RNAs (miRNAs), proteomics, metabolomics, genomics and the microbiome. Summary Although there are challenges to consider, areas for real promise and advancement in the noninvasive diagnosis of endometriosis are currently being explored with real promise in the area of miRNAs, proteomics, metabolomics, genomics and the microbiome.
In Reply to Baird et al
Stelling, Brianna E. Vaa , Vaa Stelling, Brianna E, West, Colin P.

Mayo Clinic

Academic Medicine | July 27, 2022 | Volume: 97 | Issue: 8 | Pages: 1094-1094

10.1097/acm.0000000000004739 | PMID 35917535 Get It

Clue Cells on Vaginal Wet Preparation Are Not Associated with Urinary Tract Infections or Positive Urine Cultures
Mead‐Harvey, Carolyn , Hodgson, Nicole R. , Sheele, Johnathan Michael, Hodgson, Nicole, Sheele, Johnathan M.

Mayo Clinic

Western Journal of Emergency Medicine | July 27, 2022 | Volume: 23 | Issue: 4 | Pages: 468-472

10.5811/westjem.2022.2.55000 | PMID 35980405 Get It

Introduction: Clue cells result from aberrant vaginal microflora and are associated with an increased vaginal pH, which can allow colonization of uropathogens in the vaginal introitus, increasing the risk for urinary tract infections (UTI). We sought to determine whether clue cells on vaginal wet preparation in the emergency department (ED) are associated with emergency physician diagnoses of UTIs and positive urine cultures. Methods: We conducted a retrospective analysis examining a dataset of women (≥18 years of age) who received both a genital wet preparation and urine testing in the ED. Both chi-square and multivariable regression analysis were performed. Results: We analyzed 14,952 encounters. On both univariable and multivariable analyses, emergency physicians diagnosed significantly fewer clue cell-positive women with a UTI (10.9% diagnosed with UTI vs 13.1% without UTI) (P <.001). Women with clue cells on vaginal wet preparation were not more likely to have a positive urine culture or have a urine culture growing Escherichia coli. Pregnant women with clue cells on vaginal wet preparation were not more likely to have a UTI or have a positive urine culture. Conclusion: Emergency physicians diagnosed significantly fewer women with UTIs when they found clue cells on vaginal wet preparation. Clue cells on vaginal wet preparation were not associated with an increased likelihood of a positive urine culture or having E. coli growing in the urine.
Passive wrist deviation to increase the ultrasound identified procedural safe zone in carpal tunnel syndrome: A retrospective cohort study
Shin, Alexander Y. , Brault, Jeffrey S. , Meiling, James B. , Shin, Alexander Y , Brault, Jeffrey S , Hollman, John H.

Mayo Clinic

PM&R | July 27, 2022 | Volume: 15 | Issue: 7 | Pages: 847-852

10.1002/pmrj.12876 | PMID 35895085 Get It

AbstractIntroductionCarpal tunnel syndrome (CTS) is the most common peripheral nerve entrapment syndrome. Although prior studies have explored the anatomic changes of the median nerve and carpal arch with different wrist deviations and positionings, the change in safe zone distance between the median nerve and ulnar artery with ulnar or radial wrist deviations has not been adequately investigated.ObjectiveTo identify the optimal wrist positioning that increases the safe zone distance between the median nerve and ulnar artery using ultrasound in patients with CTS.DesignRetrospective cohort study.SettingQuaternary medical center multidisciplinary outpatient hand clinic.ParticipantsTwenty five patients (41 wrists) with clinical CTS who received an electrodiagnostic study (EDX) to evaluate CTS within 1 year prior to enrollment.InterventionsUltrasound‐identified safe zone distance measurements were obtained in each patient between the ulnar aspect of the median nerve and the radial aspect of the ulnar artery with the wrist in neutral radial‐ulnar deviation as well as in passive ulnar and radial deviation.Main Outcome MeasureThe ultrasound‐identified safe zone distance with the wrist in each of the three positions.ResultsThe interstructural safe zone distance was significantly greater when measured in the ulnarly deviated position (1.08 cm) compared with either the neutral (0.61cm, p < .001) or radially deviated positions (0.52 cm, p < .001). Interstructural safe zone distance did not differ between those with normal, mild, moderate, or severe classifications of pathology, or between dominant and nondominant limbs.ConclusionThis study demonstrates that the ultrasound‐measured interstructural safe zone distance was significantly greater in the ulnarly deviated position than in either the neutral position or radially deviated position. These findings may lead to improvement in the safety of ultrasound‐guided injections.
Complete resolution of paraneoplastic syndrome of inappropriate antidiuretic hormone secretion following thymic small-cell carcinoma thoracoscopic resection
Hemmati, Pouya , Cassivi, Stephen D.

Mayo Clinic

Interactive CardioVascular and Thoracic Surgery | July 27, 2022 | Volume: 35 | Issue: 2 | Pages: No page available

10.1093/icvts/ivac192 | PMID 35894814 Get It

Abstract Thymic neuroendocrine tumours are rare anterior mediastinal neoplasms often associated with paraneoplastic syndromes. A patient presented with intractable hyponatraemia and a DOTATATE-avid mediastinal mass. Following medical optimization, she underwent thoracoscopic thymectomy with en bloc thymic small-cell carcinoma resection. Her symptoms resolved and her sodium levels normalized. In localized disease, curative-intent, minimally invasive thymic neuroendocrine tumour resection is safe and effective following preoperative staging and paraneoplastic syndrome management.
Gender and early-career faculty disparities in hematology and oncology board review lecture series
Syaj, Sebawe , Al-Kraimeen, Leen Mohammad , Akhdar, Marah , Abushukair, Hassan , Mohty, Razan , Al-Kraimeen, Leen , Al Hadidi, Samer

Mayo Clinic

Blood Advances | July 27, 2022 | Volume: 6 | Issue: 24 | Pages: 6213-6218

10.1182/bloodadvances.2022008120 | PMID 35894637 Get It

Abstract Participation of women and early-career faculty in hematology and medical oncology board review lecture series has not been studied previously. We aimed to evaluate gender and early-career faculty disparities in hematology and medical oncology board review lecture series. Speakers at major hematology and/or oncology board review lecture series meetings in the United States were analyzed in this cross-sectional study during a 5-year period from the years 2017 through 2021. Data about the lecture topic, field, speaker’s gender, years of experience, and the frequency at which the lecture was given by the speaker were collected. Of 386 speakers participating, 315 (81.6%) were ABIM (American Board of Internal Medicine)-certified. A total of 1,224 board review lectures were given in the studied period, of which 1,016 (83%) were given by an ABIM-certified speaker. Women constituted 37.7% of all speakers, with less than 50% representation in five out of six courses. Lectures discussing malignant hematology topics had the lowest proportion of women presenters (24.8%), followed by solid tumors (38.9%) and benign hematology lectures (44.1%). Faculty with more than 15 years since initial certification presented more than 50% of lectures. The median time from initial hematology or medical oncology certification to lecture presentation was 12.5 years and 14 years, respectively. A positive trend in the participation of women was found at all board review conferences across the studied period. Our data suggest that women and early-career faculty participation in hematology and oncology board review series is inadequate.
Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19
Neha, Gupta,, Lisa, Settle,, R, Brown, Brent, L, Armaignac, Donna, Michael, Baram,, E, Perkins, Nicholas, Margit, Kaufman,, R, Melamed, Roman, B, Christie, Amy, C, Danesh, Valerie, L, Denson, Joshua, R, Cheruku, Sreekanth, Karen, Boman,, Vikas, Bansal,, K, Kumar, Vishakha, J, Walkey, Allan, P, Domecq, Juan, Rahul, Kashyap,, E, Aston, Christopher, Bansal, Vikas , Choudhry, Asad , Tonna, Joseph E. , Kaur, Nirmaljot , Danesh, Valerie , Mosier, Jarrod , Заболотских, И. Б. , Montgomery, Vicki , Heneghan, Julia A. , Menon, Shina , Gupta, Neha , Kovačević, Peđja , Lee‐Mateus, Alejandra Yu , Asghar, Muhammad Sohaib , O’Brien, Connor , Popadić, Višeslav , Shlomovich, Mark , Almazyad, Mohammed , Nawathe, Pooja , Lyons, Patrick G. , El‐Kassas, Mohamed , Tawheed, Ahmed , Pineda, Estela , Parameswaran, Sreejith , Iwasaki, Yudai , Galadanci, Hadiza , Kovačević, Bojan , Nenadić, Irina , Djuric, Marko , DiLorenzo, Madeline A. , Minear, Steven , Perkins, Nicholas , Fitzsimmons, Alec , Maldonado, Génessis , Tarabichi, Yasir , Redfern, Roberta E. , Vail, Emily A. , Dy, Rajany , Spuzzillo, Anthony , Galet, Colette , Akça, Ozan , Cavallazzi, Rodrigo , Pulsipher, Aaron M. , Domecq, Juan P, Tonna, Joseph E. , Bansal, Vikas , Yu Lee-Mateus, Alejandra , Kaur, Nirmaljot , Asghar, Muhammad S , Popadic, Viseslav , O'Brien, Connor G , Mosier, Jarrod M , Domecq Graces, Juan Pablo , Redfern, Roberta E , Pulsipher, Aaron M , Sines, B. , Menon, Shina , Settle, Lisa, Brown, Brent R., Armaignac, Donna Lee , Baram, Michael , Kaufman, Margit, Melamed, Roman , Christie, Amy B. , Denson, Joshua L. , Cheruku, Sreekanth , Boman, Karen , Kumar, Vishakha K. , Walkey, Allan J. , Domecq, Juan Pablo , Kashyap, Rahul , Aston, Christopher E. , Group, on behalf of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator, Surapaneni, Krishna Mohan

Mayo Clinic

Critical Care Medicine | July 27, 2022 | Volume: 50 | Issue: 10 | Pages: e744-e758

10.1097/ccm.0000000000005627 | PMID 35894609 Get It

OBJECTIVES: To determine the association of prior use of renin-angiotensin-aldosterone system inhibitors (RAASIs) with mortality and outcomes in hospitalized patients with COVID-19. DESIGN: Retrospective observational study. SETTING: Multicenter, international COVID-19 registry. Subjects: Adult hospitalized COVID-19 patients on antihypertensive agents (AHAs) prior to admission, admitted from March 31, 2020, to March 10, 2021. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Data were compared between three groups: patients on RAASIs only, other AHAs only, and those on both medications. Multivariable logistic and linear regressions were performed after controlling for prehospitalization characteristics to estimate the effect of RAASIs on mortality and other outcomes during hospitalization. Of 26,652 patients, 7,975 patients were on AHAs prior to hospitalization. Of these, 1,542 patients (19.3%) were on RAASIs only, 3,765 patients (47.2%) were on other AHAs only, and 2,668 (33.5%) patients were on both medications. Compared with those taking other AHAs only, patients on RAASIs only were younger (mean age 63.3 vs 66.9 yr; p < 0.0001), more often male (58.2% vs 52.4%; p = 0.0001) and more often White (55.1% vs 47.2%; p < 0.0001). After adjusting for age, gender, race, location, and comorbidities, patients on combination of RAASIs and other AHAs had higher in-hospital mortality than those on RAASIs only (odds ratio [OR] = 1.28; 95% CI [1.19–1.38]; p < 0.0001) and higher mortality than those on other AHAs only (OR = 1.09; 95% CI [1.03–1.15]; p = 0.0017). Patients on RAASIs only had lower mortality than those on other AHAs only (OR = 0.87; 95% CI [0.81–0.94]; p = 0.0003). Patients on ACEIs only had higher mortality compared with those on ARBs only (OR = 1.37; 95% CI [1.20–1.56]; p < 0.0001). CONCLUSIONS: Among patients hospitalized for COVID-19 who were taking AHAs, prior use of a combination of RAASIs and other AHAs was associated with higher in-hospital mortality than the use of RAASIs alone. When compared with ARBs, ACEIs were associated with significantly higher mortality in hospitalized COVID-19 patients.
Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study
Breuer, Eva , Doyle, Majella B. , Yang, Liu , Anwar, Imran J. , Merani, Shaheed , Limkemann, Ashley , Jeddou, Heithem , Kim, Steven C. , Nassar, Ahmed , Vibert, Éric , Oliveira, Michelle, Cherqui, Daniel , Porte, Robert J. , Magliocca, Joseph F. , Fischer, Lutz , Zieniewicz, Krzysztof , Ramı́rez, Pablo , Foley, David P. , Langnas, Alan N. , Polak, Wojciech G. , Rosen, Charles B. , Dutkowski, Philipp , Clavien, Pierre‐Alain , Chapman, William C. , Taner, C. Burcin , Clavien, Pierre-Alain , Chapman, William C , Polak, Wojciech G , Mueller, Matteo , Murad, Sarwa Darwish , López‐López, Víctor , Hoogwater, Frederik J.H. , Fondevila, Constantino , Boudjéma, Karim , Schenk, Austin D. , Knechtle, Stuart J. , Chapman, William C. , Gores, Gregory J. , Heimbach, Julie K. , Yang, Liu

Mayo Clinic

Annals of Surgery | July 27, 2022 | Volume: 276 | Issue: 5 | Pages: 846-853

10.1097/sla.0000000000005641 | PMID 35894433 Get It

Objective: To define benchmark values for liver transplantation (LT) in patients with perihilar cholangiocarcinoma (PHC) enabling unbiased comparisons. Background: Transplantation for PHC is used with reluctance in many centers and even contraindicated in several countries. Although benchmark values for LT are available, there is a lack of specific data on LT performed for PHC. Methods: PHC patients considered for LT after Mayo-like protocol were analyzed in 17 reference centers in 2 continents over the recent 5-year period (2014–2018). The minimum follow-up was 1 year. Benchmark patients were defined as operated at high-volume centers (≥50 overall LT/year) after neoadjuvant chemoradiotherapy, with a tumor diameter <3 cm, negative lymph nodes, and with the absence of relevant comorbidities. Benchmark cutoff values were derived from the 75th to 25th percentiles of the median values of all benchmark centers. Results: One hundred thirty-four consecutive patients underwent LT after completion of the neoadjuvant treatment. Of those, 89.6% qualified as benchmark cases. Benchmark cutoffs were 90-day mortality ≤5.2%; comprehensive complication index at 1 year of ≤33.7; grade ≥3 complication rates ≤66.7%. These values were better than benchmark values for other indications of LT. Five-year disease-free survival was largely superior compared with a matched group of nodal negative patients undergoing curative liver resection (n=106) (62% vs 32%, P<0.001). Conclusion: This multicenter benchmark study demonstrates that LT offers excellent outcomes with superior oncological results in early stage PHC patients, even in candidates for surgery. This provocative observation should lead to a change in available therapeutic algorithms for PHC.
Change in Morphological Features of Enlarged Subarachnoid Spaces Following Treatment in Idiopathic Normal Pressure Hydrocephalus
Camerucci, Emanuele , Graff‐Radford, Jonathan , Elder, Benjamin D. , Gunter, Jeffrey L. , Cutsforth‐Gregory, Jeremy K. , Murphy, Matthew C. , Davidge‐Pitts, Caroline , Davidge-Pitts, Caroline, Cogswell, Petrice M , Jones, David T. , Botha, Hugo , Johnson, Derek R. , Jack, Clifford R. , Huston, John , Cogswell, Petrice M.

Mayo Clinic

Journal of Magnetic Resonance Imaging | July 27, 2022 | Volume: 57 | Issue: 5 | Pages: 1443-1450

10.1002/jmri.28340 | PMID 35894392 Get It

BackgroundFocally enlarged sulci (FES) are areas of proposed extraventricular fluid entrapment that may occur within idiopathic normal pressure hydrocephalus (iNPH) with radiographic evidence of disproportionately enlarged subarachnoid‐space hydrocephalus (DESH), and should be differentiated from atrophy.PurposeTo evaluate for change in FES size and pituitary height after shunt placement in iNPH.Study typeRetrospective.SubjectsA total of 125 iNPH patients who underwent shunt surgery and 40 age‐matched controls.Field Strength/Sequence1.5 T and 3 T. Axial T2w FLAIR, 3D T1w MPRAGE, 2D sagittal T1w.AssessmentFES were measured in three dimensions and volume was estimated by assuming an ellipsoid shape. Pituitary gland height was measured in the mid third of the gland in iNPH patients and controls.Statistical testsWilcoxon signed‐rank test for comparisons between MRI measurements; Wilcoxon rank sum test for comparison of cases/controls. Significance level was P < 0.05.ResultsFifty percent of the patients had FES. FES volume significantly decreased between the pre and first postshunt MRI by a median of 303 mm3 or 30.0%. Pituitary gland size significantly increased by 0.48 mm or 14.4%. FES decreased significantly by 190 mm3 or 23.1% and pituitary gland size increased significantly by 0.25 mm or 6% between the first and last postshunt MRI.Data ConclusionDecrease in size of FES after shunt placement provides further evidence that these regions are due to disordered cerebrospinal fluid (CSF) dynamics and should not be misinterpreted as atrophy. A relatively smaller pituitary gland in iNPH patients that normalizes after shunt is a less‐well recognized feature of altered CSF dynamics.Evidence Level3Technical EfficacyStage 2